Literature DB >> 24166951

Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization.

Adelfia Talà1, Laura Cogli, Mario De Stefano, Marcella Cammarota, Maria Rita Spinosa, Cecilia Bucci, Pietro Alifano.   

Abstract

We have previously shown that during late stages of the infectious process, serogroup B meningococci (MenB) are able to escape the phagosome of in vitro-infected human epithelial cells. They then multiply in the cytosolic environment and spread intracellularly and to surrounding cells by exploiting the microtubule cytoskeleton, as suggested by results of infections in the presence of microtubule inhibitors and evidence of nanotubes connecting neighboring cells. In this study, by using microtubule binding assays with purified microtubule asters and bundles and microtubule bundles synthesized in vitro, we demonstrate that the MenB capsule directly mediates the interaction between bacteria and microtubules. The direct interaction between the microtubules and the MenB capsular polysaccharide was confirmed by coimmunoprecipitation experiments. Unexpectedly, serogroup C meningococci (MenC), which have a capsular polysaccharide that differs from that of MenB only by its anomeric linkage, α(2→9) instead of α(2→8), were not able to interact with the microtubules, and the lack of interaction was not due to capsular polysaccharide O-acetylation that takes place in most MenC strains but not in MenB strains. Moreover, we demonstrate that the MenB capsular polysaccharide inhibits tubulin polymerization in vitro. Thus, at variance with MenC, MenB may interfere with microtubule dynamics during cell infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166951      PMCID: PMC3911844          DOI: 10.1128/IAI.00501-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  Actin and microtubules in cell motility: which one is in control?

Authors:  Sandrine Etienne-Manneville
Journal:  Traffic       Date:  2004-07       Impact factor: 6.215

2.  Meningococcal vaccines: WHO position paper, November 2011.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2011-11-18

3.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37.

Authors:  Allison Jones; Miriam Geörg; Lisa Maudsdotter; Ann-Beth Jonsson
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

5.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

6.  Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens.

Authors:  F P de Vries; A van Der Ende; J P van Putten; J Dankert
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

Authors:  I Smith; D A Caugant; E A Høiby; T Wentzel-Larsen; A Halstensen
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

8.  The HrpB-HrpA two-partner secretion system is essential for intracellular survival of Neisseria meningitidis.

Authors:  Adelfia Talà; Cinzia Progida; Mario De Stefano; Laura Cogli; Maria Rita Spinosa; Cecilia Bucci; Pietro Alifano
Journal:  Cell Microbiol       Date:  2008-08-25       Impact factor: 3.715

9.  Strucutres of the capsular polysaccharides of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance spectroscopy.

Authors:  H J Jennings; A K Bhattacharjee; D R Bundle; C P Kenny; A Martin; I C Smith
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

Authors:  Maria Jose Uria; Qian Zhang; Yanwen Li; Angel Chan; Rachel M Exley; Bridget Gollan; Hannah Chan; Ian Feavers; Andy Yarwood; Raquel Abad; Ray Borrow; Roland A Fleck; Barbara Mulloy; Julio A Vazquez; Christoph M Tang
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

View more
  4 in total

Review 1.  Regulation of capsule in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Jennifer Thomas; David S Stephens
Journal:  Crit Rev Microbiol       Date:  2015-06-19       Impact factor: 7.624

2.  Virulence Traits of a Serogroup C Meningococcus and Isogenic cssA Mutant, Defective in Surface-Exposed Sialic Acid, in a Murine Model of Meningitis.

Authors:  Roberta Colicchio; Chiara Pagliuca; Susanna Ricci; Elena Scaglione; Denis Grandgirard; Ilias Masouris; Fabrizio Farina; Caterina Pagliarulo; Giuseppe Mantova; Laura Paragliola; Stephen L Leib; Uwe Koedel; Gianni Pozzi; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

3.  Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.

Authors:  Roberta Colicchio; Chiara Pagliuca; Gabiria Pastore; Annunziata Gaetana Cicatiello; Caterina Pagliarulo; Adelfia Talà; Elena Scaglione; Josè Camilla Sammartino; Cecilia Bucci; Pietro Alifano; Paola Salvatore
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

Review 4.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.